Global Pharmaceutical Contract Research Organization (CRO) Market 2022-2030 by Service, Therapeutic Application, End User, and Region: Trend Forecast and Growth Opportunity
- Report ID: 29910
- Date: Jun, 2022
- Pages: 194
- Category: Healthcare & Pharmaceuticals
Global pharmaceutical contract research organization (CRO) market will reach $45.0 billion by 2030, growing by 9.8% annually over 2021-2030, driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity.
Highlighted with 118 tables and 80 figures, this 194-page report “Global Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therapeutic Application, End User, and Region: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire global pharmaceutical contract research organization (CRO) market and all its sub-segments through extensively detailed classifications.
Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2030 with 2021 as the base year.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global pharmaceutical contract research organization (CRO) market in every aspect of the classification from perspectives of Service, Therapeutic Application, End User, and Region.
Based on Service, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.
• CRO for Pre-clinical Development
• CRO for Phase I Trials
• CRO for Phase II Trials
• CRO for Phase III Trials
• CRO for Phase IV Trials
• Laboratory Services
• Consulting Services
• Data Management Services
Based on Therapeutic Application, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.
• Infectious Diseases
• Oncology
• Metabolic Disorders
• Cardiovascular Disorders
• Central Nervous System
• Respiratory Disorders
• Gastrointestinal Disorders
• Other Therapeutic Applications
By End User, the global market is segmented into the following sub-markets with annual revenue ($ bn) for 2021-2030 included in each section.
• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Companies
• Academic Institutes
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, Other Nations)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ bn) are available for 2021-2030. The breakdown of all regional markets by country and split of key national markets by Service, Therapeutic Application, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Charles River Laboratories
CMIC Co. Ltd
Covance Inc.
Hangzhou Tigermed Consulting Co., Ltd.
ICON Plc
IQVIA Holdings Inc.
LSK Global Pharma Service Co., Ltd.
Novotech Pty Ltd
PAREXEL International Corporation
Pharmaceutical Product Development LLC (PPD)
PRA Health Sciences Inc.
Quanticate Ltd
Samsung Bioepis Co., Ltd.
SGS SA (SGS Life Sciences)
Syneos Health Inc.
WuXi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 22
2.1 Market Size and Forecast 22
2.1.1 Impact of COVID-19 on World Economy 23
2.1.2 Impact of COVID-19 on the Market 25
2.2 Major Growth Drivers 27
2.3 Market Restraints and Challenges 35
2.4 Emerging Opportunities and Market Trends 38
2.5 Porter’s Fiver Forces Analysis 42
3 Segmentation of Global Market by Service 46
3.1 Market Overview by Service 46
3.2 CRO for Pre-clinical Development 48
3.3 CRO for Phase I Trials 49
3.4 CRO for Phase II Trials 50
3.5 CRO for Phase III Trials 51
3.6 CRO for Phase IV Trials 52
3.7 Laboratory Services 53
3.8 Consulting Services 54
3.9 Data Management Services 55
4 Segmentation of Global Market by Therapeutic Application 56
4.1 Market Overview by Therapeutic Application 56
4.2 Infectious Diseases 58
4.3 Oncology 59
4.4 Metabolic Disorders 60
4.5 Cardiovascular Disorders 61
4.6 Central Nervous System 62
4.7 Respiratory Disorders 63
4.8 Gastrointestinal Disorders 64
4.9 Other Therapeutic Applications 65
5 Segmentation of Global Market by End User 66
5.1 Market Overview by End User 66
5.2 Pharmaceutical & Biopharmaceutical Companies 68
5.3 Medical Device Companies 69
5.4 Academic Institutes 70
6 Segmentation of Global Market by Region 71
6.1 Geographic Market Overview 2019-2030 71
6.2 North America Market 2019-2030 by Country 75
6.2.1 Overview of North America Market 75
6.2.2 U.S. 79
6.2.3 Canada 82
6.2.4 Mexico 84
6.3 European Market 2019-2030 by Country 86
6.3.1 Overview of European Market 86
6.3.2 Germany 90
6.3.3 UK 92
6.3.4 France 94
6.3.5 Spain 96
6.3.6 Italy 98
6.3.7 Russia 100
6.3.8 Rest of European Market 102
6.4 Asia-Pacific Market 2019-2030 by Country 104
6.4.1 Overview of Asia-Pacific Market 104
6.4.2 Japan 108
6.4.3 China 111
6.4.4 Australia 113
6.4.5 India 115
6.4.6 South Korea 117
6.4.7 Rest of APAC Region 119
6.5 South America Market 2019-2030 by Country 121
6.5.1 Argentina 124
6.5.2 Brazil 126
6.5.3 Chile 128
6.5.4 Rest of South America Market 130
6.6 MEA Market 2019-2030 by Country 131
6.6.1 UAE 134
6.6.2 Saudi Arabia 136
6.6.3 South Africa 138
6.6.4 Other National Markets 140
7 Competitive Landscape 141
7.1 Overview of Key Vendors 141
7.2 New Product Launch, Partnership, Investment, and M&A 145
7.3 Company Profiles 146
Charles River Laboratories 146
CMIC Co. Ltd 148
Covance Inc. 150
Hangzhou Tigermed Consulting Co., Ltd. 154
ICON Plc 157
IQVIA Holdings Inc. 160
LSK Global Pharma Service Co., Ltd. 164
Novotech Pty Ltd 166
PAREXEL International Corporation 168
Pharmaceutical Product Development LLC (PPD) 172
PRA Health Sciences Inc. 174
Quanticate Ltd 176
Samsung Bioepis Co., Ltd. 178
SGS SA (SGS Life Sciences) 180
Syneos Health Inc. 183
WuXi AppTec Inc. 186
8 Investing in Global Market: Risk Assessment and Management 188
8.1 Risk Evaluation of Global Market 188
8.2 Critical Success Factors (CSFs) 191
Related Reports and Products 194
List of Tables
Table 1. Snapshot of Global Pharmaceutical CRO Market in Balanced Perspective, 2019-2030 20
Table 2. World Economic Outlook, 2021-2030 24
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 29
Table 4. Worldwide Total Number of Registered Clinical Trials 31
Table 5. World Health Spending by Region, $ bn, 2013-2020 34
Table 6. Main Product Trends and Market Opportunities in Global Pharmaceutical CRO Market 38
Table 7. Global Pharmaceutical CRO Market by Service, 2019-2030, $ bn 46
Table 8. Global Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 56
Table 9. Global Pharmaceutical CRO Market by End User, 2019-2030, $ bn 66
Table 10. Global Pharmaceutical CRO Market by Region, 2019-2030, $ bn 72
Table 11. Leading National Pharmaceutical CRO Market, 2021 and 2030, $ bn 74
Table 12. North America Pharmaceutical CRO Market by Country, 2019-2030, $ bn 77
Table 13. U.S. Pharmaceutical CRO Market by Service, 2019-2030, $ bn 81
Table 14. U.S. Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 81
Table 15. U.S. Pharmaceutical CRO Market by End User, 2019-2030, $ bn 81
Table 16. Canada Pharmaceutical CRO Market by Service, 2019-2030, $ bn 83
Table 17. Canada Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 83
Table 18. Canada Pharmaceutical CRO Market by End User, 2019-2030, $ bn 83
Table 19. Mexico Pharmaceutical CRO Market by Service, 2019-2030, $ bn 85
Table 20. Mexico Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 85
Table 21. Mexico Pharmaceutical CRO Market by End User, 2019-2030, $ bn 85
Table 22. Europe Pharmaceutical CRO Market by Country, 2019-2030, $ bn 89
Table 23. Germany Pharmaceutical CRO Market by Service, 2019-2030, $ bn 91
Table 24. Germany Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 91
Table 25. Germany Pharmaceutical CRO Market by End User, 2019-2030, $ bn 91
Table 26. UK Pharmaceutical CRO Market by Service, 2019-2030, $ bn 93
Table 27. UK Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 93
Table 28. UK Pharmaceutical CRO Market by End User, 2019-2030, $ bn 93
Table 29. France Pharmaceutical CRO Market by Service, 2019-2030, $ bn 95
Table 30. France Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 95
Table 31. France Pharmaceutical CRO Market by End User, 2019-2030, $ bn 95
Table 32. Spain Pharmaceutical CRO Market by Service, 2019-2030, $ bn 97
Table 33. Spain Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 97
Table 34. Spain Pharmaceutical CRO Market by End User, 2019-2030, $ bn 97
Table 35. Italy Pharmaceutical CRO Market by Service, 2019-2030, $ bn 99
Table 36. Italy Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 99
Table 37. Italy Pharmaceutical CRO Market by End User, 2019-2030, $ bn 99
Table 38. Russia Pharmaceutical CRO Market by Service, 2019-2030, $ bn 101
Table 39. Russia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 101
Table 40. Russia Pharmaceutical CRO Market by End User, 2019-2030, $ bn 101
Table 41. Pharmaceutical CRO Market in Rest of Europe by Country, 2019-2030, $ bn 103
Table 42. APAC Pharmaceutical CRO Market by Country, 2019-2030, $ bn 106
Table 43. Japan Pharmaceutical CRO Market by Service, 2019-2030, $ bn 110
Table 44. Japan Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 110
Table 45. Japan Pharmaceutical CRO Market by End User, 2019-2030, $ bn 110
Table 46. China Pharmaceutical CRO Market by Service, 2019-2030, $ bn 112
Table 47. China Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 112
Table 48. China Pharmaceutical CRO Market by End User, 2019-2030, $ bn 112
Table 49. Australia Pharmaceutical CRO Market by Service, 2019-2030, $ bn 114
Table 50. Australia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 114
Table 51. Australia Pharmaceutical CRO Market by End User, 2019-2030, $ bn 114
Table 52. India Pharmaceutical CRO Market by Service, 2019-2030, $ bn 116
Table 53. India Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 116
Table 54. India Pharmaceutical CRO Market by End User, 2019-2030, $ bn 116
Table 55. South Korea Pharmaceutical CRO Market by Service, 2019-2030, $ bn 118
Table 56. South Korea Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 118
Table 57. South Korea Pharmaceutical CRO Market by End User, 2019-2030, $ bn 118
Table 58. Pharmaceutical CRO Market in Rest of APAC by Country, 2019-2030, $ bn 120
Table 59. South America Pharmaceutical CRO Market by Country, 2019-2030, $ bn 123
Table 60. Argentina Pharmaceutical CRO Market by Service, 2019-2030, $ bn 125
Table 61. Argentina Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 125
Table 62. Argentina Pharmaceutical CRO Market by End User, 2019-2030, $ bn 125
Table 63. Brazil Pharmaceutical CRO Market by Service, 2019-2030, $ bn 127
Table 64. Brazil Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 127
Table 65. Brazil Pharmaceutical CRO Market by End User, 2019-2030, $ bn 127
Table 66. Chile Pharmaceutical CRO Market by Service, 2019-2030, $ bn 129
Table 67. Chile Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 129
Table 68. Chile Pharmaceutical CRO Market by End User, 2019-2030, $ bn 129
Table 69. MEA Pharmaceutical CRO Market by Country, 2019-2030, $ bn 133
Table 70. UAE Pharmaceutical CRO Market by Service, 2019-2030, $ bn 135
Table 71. UAE Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 135
Table 72. UAE Pharmaceutical CRO Market by End User, 2019-2030, $ bn 135
Table 73. Saudi Arabia Pharmaceutical CRO Market by Service, 2019-2030, $ bn 137
Table 74. Saudi Arabia Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 137
Table 75. Saudi Arabia Pharmaceutical CRO Market by End User, 2019-2030, $ bn 137
Table 76. South Africa Pharmaceutical CRO Market by Service, 2019-2030, $ bn 139
Table 77. South Africa Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, $ bn 139
Table 78. South Africa Pharmaceutical CRO Market by End User, 2019-2030, $ bn 139
Table 79. Breakdown of World Market by Key Vendor, 2020, % 143
Table 80. Charles River Laboratories: Company Snapshot 146
Table 81. Charles River Laboratories: Product Portfolio 147
Table 82. CMIC Co. Ltd.: Company Snapshot 148
Table 83. CMIC Co. Ltd.: Business Segmentation 149
Table 84. CMIC Co. Ltd.: Revenue by Region, 2018, % 149
Table 85. Covance Inc.: Company Snapshot 150
Table 86. Covance Inc.: Product Portfolio 151
Table 87. Covance Inc.: Revenue by Region, 2020, % 152
Table 88. Hangzhou Tigermed Consulting Co., Ltd.: Company Snapshot 154
Table 89. Hangzhou Tigermed Consulting Co., Ltd.: Business Segmentation 155
Table 90. ICON Plc: Company Snapshot 157
Table 91. ICON Plc: Business Segmentation 157
Table 92. ICON Plc: Product Portfolio 158
Table 93. ICON Plc: Revenue by Region, 2020, % 158
Table 94. IQVIA Holdings Inc.: Company Snapshot 160
Table 95. IQVIA Holdings Inc.: Business Segmentation 161
Table 96. IQVIA Holdings Inc.: Revenue by Region, 2020, % 161
Table 97. IQVIA Holdings Inc.: Product Portfolio 162
Table 98. LSK Global Pharma Service Co., Ltd.: Company Snapshot 164
Table 99. Novotech Pty Ltd: Company Snapshot 166
Table 100. PAREXEL International Corporation: Company Snapshot 168
Table 101. PAREXEL International Corporation: Business Segmentation 169
Table 102. PAREXEL International Corporation: Revenue by Region, 2018, % 169
Table 103. PAREXEL International Corporation: Product Portfolio 170
Table 104. Pharmaceutical Product Development LLC (PPD): Company Snapshot 172
Table 105. PRA Health Sciences Inc.: Company Snapshot 174
Table 106. PRA Health Sciences Inc.: Business Segmentation 175
Table 107. PRA Health Sciences Inc.: Revenue by Region, 2018, % 175
Table 108. Quanticate Ltd: Company Snapshot 176
Table 109. Samsung Bioepis Co., Ltd.: Company Snapshot 178
Table 110. SGS SA (SGS Life Sciences): Company Snapshot 180
Table 111. SGS SA (SGS Life Sciences): Business Segmentation 181
Table 112. SGS SA (SGS Life Sciences): Revenue by Region, 2018, % 181
Table 113. Syneos Health Inc.: Company Snapshot 183
Table 114. Syneos Health Inc.: Business Segmentation 184
Table 115. Syneos Health Inc.: Revenue by Region, 2018, % 184
Table 116. WuXi AppTec Inc.: Company Snapshot 186
Table 117. Risk Evaluation for Investing in Global Market, 2021-2030 189
Table 118. Critical Success Factors and Key Takeaways 192
List of Figures
Figure 1. Research Method Flow Chart 13
Figure 2. Breakdown of Primary Research 15
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 17
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2030 19
Figure 5. Global Pharmaceutical CRO Market, 2019-2030, $ bn 22
Figure 6. Impact of COVID-19 on Business 25
Figure 7. Primary Drivers and Impact Factors of Global Pharmaceutical CRO Market 27
Figure 8. Leading Causes of Death in the World, 2019-2020, million 32
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 33
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 33
Figure 11. Primary Restraints and Impact Factors of Global Pharmaceutical CRO Market 35
Figure 12. Investment Opportunity Analysis 39
Figure 13. Porter’s Fiver Forces Analysis of Global Pharmaceutical CRO Market 42
Figure 14. Breakdown of Global Pharmaceutical CRO Market by Service, 2019-2030, % of Sales Revenue 47
Figure 15. Global Addressable Market Cap in 2022-2030 by Service, Value ($ bn) and Share (%) 47
Figure 16. Global Pharmaceutical CRO Market: CRO for Pre-clinical Development, 2019-2030, $ bn 48
Figure 17. Global Pharmaceutical CRO Market: CRO for Phase I Trials, 2019-2030, $ bn 49
Figure 18. Global Pharmaceutical CRO Market: CRO for Phase II Trials, 2019-2030, $ bn 50
Figure 19. Global Pharmaceutical CRO Market: CRO for Phase III Trials, 2019-2030, $ bn 51
Figure 20. Global Pharmaceutical CRO Market: CRO for Phase IV Trials, 2019-2030, $ bn 52
Figure 21. Global Pharmaceutical CRO Market: Laboratory Services, 2019-2030, $ bn 53
Figure 22. Global Pharmaceutical CRO Market: Consulting Services, 2019-2030, $ bn 54
Figure 23. Global Pharmaceutical CRO Market: Data Management Services, 2019-2030, $ bn 55
Figure 24. Breakdown of Global Pharmaceutical CRO Market by Therapeutic Application, 2019-2030, % of Sales Revenue 57
Figure 25. Global Addressable Market Cap in 2022-2030 by Therapeutic Application, Value ($ bn) and Share (%) 57
Figure 26. Global Pharmaceutical CRO Market: Infectious Diseases, 2019-2030, $ bn 58
Figure 27. Global Pharmaceutical CRO Market: Oncology, 2019-2030, $ bn 59
Figure 28. Global Pharmaceutical CRO Market: Metabolic Disorders, 2019-2030, $ bn 60
Figure 29. Global Pharmaceutical CRO Market: Cardiovascular Disorders, 2019-2030, $ bn 61
Figure 30. Global Pharmaceutical CRO Market: Central Nervous System, 2019-2030, $ bn 62
Figure 31. Global Pharmaceutical CRO Market: Respiratory Disorders, 2019-2030, $ bn 63
Figure 32. Global Pharmaceutical CRO Market: Gastrointestinal Disorders, 2019-2030, $ bn 64
Figure 33. Global Pharmaceutical CRO Market: Other Therapeutic Applications, 2019-2030, $ bn 65
Figure 34. Breakdown of Global Pharmaceutical CRO Market by End User, 2019-2030, % of Revenue 67
Figure 35. Global Addressable Market Cap in 2022-2030 by End User, Value ($ bn) and Share (%) 67
Figure 36. Global Pharmaceutical CRO Market: Pharmaceutical & Biopharmaceutical Companies, 2019-2030, $ bn 68
Figure 37. Global Pharmaceutical CRO Market: Medical Device Companies, 2019-2030, $ bn 69
Figure 38. Global Pharmaceutical CRO Market: Academic Institutes, 2019-2030, $ bn 70
Figure 39. Global Market Snapshot by Region 71
Figure 40. Geographic Spread of Worldwide Pharmaceutical CRO Market, 2019-2030, % of Sales Revenue 72
Figure 41. Global Addressable Market Cap in 2022-2030 by Region, Value ($ bn) and Share (%) 73
Figure 42. North American Pharmaceutical CRO Market, 2019-2030, $ bn 76
Figure 43. Breakdown of North America Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue 77
Figure 44. Contribution to North America 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 78
Figure 45. U.S. Pharmaceutical CRO Market, 2019-2030, $ bn 80
Figure 46. Canada Pharmaceutical CRO Market, 2019-2030, $ bn 82
Figure 47. Pharmaceutical CRO Market in Mexico, 2015-2030, $ bn 84
Figure 48. European Pharmaceutical CRO Market, 2019-2030, $ bn 87
Figure 49. Breakdown of European Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue 88
Figure 50. Contribution to Europe 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 89
Figure 51. Pharmaceutical CRO Market in Germany, 2019-2030, $ bn 90
Figure 52. Pharmaceutical CRO Market in UK, 2019-2030, $ bn 92
Figure 53. Pharmaceutical CRO Market in France, 2019-2030, $ bn 94
Figure 54. Pharmaceutical CRO Market in Spain, 2019-2030, $ bn 96
Figure 55. Pharmaceutical CRO Market in Italy, 2019-2030, $ bn 98
Figure 56. Pharmaceutical CRO Market in Russia, 2019-2030, $ bn 100
Figure 57. Pharmaceutical CRO Market in Rest of Europe, 2019-2030, $ bn 102
Figure 58. Asia-Pacific Pharmaceutical CRO Market, 2019-2030, $ bn 105
Figure 59. Breakdown of APAC Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue 105
Figure 60. Contribution to APAC 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 107
Figure 61. Pharmaceutical CRO Market in Japan, 2019-2030, $ bn 109
Figure 62. Pharmaceutical CRO Market in China, 2019-2030, $ bn 111
Figure 63. Pharmaceutical CRO Market in Australia, 2019-2030, $ bn 113
Figure 64. Pharmaceutical CRO Market in India, 2019-2030, $ bn 115
Figure 65. Pharmaceutical CRO Market in South Korea, 2019-2030, $ bn 117
Figure 66. Pharmaceutical CRO Market in Rest of APAC, 2019-2030, $ bn 119
Figure 67. South America Pharmaceutical CRO Market, 2019-2030, $ bn 122
Figure 68. Breakdown of South America Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue 122
Figure 69. Contribution to South America 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 123
Figure 70. Pharmaceutical CRO Market in Argentina, 2019-2030, $ bn 124
Figure 71. Pharmaceutical CRO Market in Brazil, 2019-2030, $ bn 126
Figure 72. Pharmaceutical CRO Market in Chile, 2019-2030, $ bn 128
Figure 73. Pharmaceutical CRO Market in Rest of South America, 2019-2030, $ bn 130
Figure 74. Pharmaceutical CRO Market in MEA, 2019-2030, $ bn 132
Figure 75. Breakdown of MEA Pharmaceutical CRO Market by Country, 2021 and 2030, % of Revenue 132
Figure 76. Contribution to MEA 2022-2030 Cumulative Revenue by Country, Value ($ bn) and Share (%) 133
Figure 77. Pharmaceutical CRO Market in UAE, 2019-2030, $ bn 134
Figure 78. Pharmaceutical CRO Market in Saudi Arabia, 2019-2030, $ bn 136
Figure 79. Pharmaceutical CRO Market in South Africa, 2019-2030, $ bn 138
Figure 80. Growth Stage of Global Pharmaceutical CRO Industry over the Forecast Period 141
Research methodology is mainly referring to the practical how of any offered piece of research. More specifically, it’s all about how a researcher systematically designs a study in order to assure extremely valid as well as reliable results that ultimately address the targets and objectives of the research.
In any formal research including academic journal, article, dissertation and so on, there will be a special section on a research methodology that mainly describes what, by whom, how to gather as well as how to evaluate the data are provided.
This research methodology has been segmented into following types:
Primary Research:
It is said to be original information that the researchers collect for the crucial purposes of answering the research questions of readers with the help of surveys, observations and experiments.
Secondary Research:
The secondary research is the data that has already been collected by various other researchers in the form of government analysis or scientific studies.
Qualitative Research:
It is descriptive and subjective method irrespective of facts. Both observation and description are essential in this type of research methodology. Its main vision is to analyze knowledge, attitudes, behaviours as well as opinions of people related to the topic of any research. This method has been operated through grounded research, case study and actionable research.
Quantitative Research:
It contains several laboratory experiments, basic surveys, mathematical calculations, simulations and so on. The possible measurement, quantity or amount is considered to be a major factor in the quantitative research methodology.
Clients
